We culture and isolate monoclonal cells, then perform functional validation and expression profiling to screen for stable, high-expressing cell lines on chip through OptoBot® 1000 or its series products. Our integrated workflow uses precision single-cell manipulation to screen for high-yield cell lines in as little as five days.